编号：201801 证券代码：000920 证券简称：南方汇通 南方汇通股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------|-----------------------------|--------------------------------------------------------| | | | | | 投资者关 | □ 特定对象调研 | □ 分析师会议 | | 系活动类 | □ 媒体采访 | □ 业绩说明会 | | 别 | □ 新闻发布会 | □ 路演活动 | | | √ 现场参观 | | | | □ 其他 | | | 参 与 单 | 许刚 | | | 位名称 | | | | 时间 | 2018 年 6 月 4 日 | | | 地点 | 公司会议室 | | | 上市公司 | 张小滨 | | | 接待人员 | | | | 姓名 | | | | 投资者关 | 1 、公司未来外延发展方向？ | | | 系活动主 要内容 | | 未来重点将以复合反渗透膜作为产业发展核心，向纵横双向产 | | | | 业链延伸，重点考虑与公司能够实现协同的产业 ...

编号：201803 证券代码：000920 证券简称：南方汇通 南方汇通股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------|------------------------------|--------------------------------------------------------| | | | | | 投资者关 | R 特定对象调研 | □ 分析师会议 | | 系活动类 | □ 媒体采访 | □ 业绩说明会 | | 别 | □ 新闻发布会 | £ 路演活动 | | | □ 现场参观 | | | | □ 其他 | | | 参 与 单 | 方正证券股份有限公司 | | | 位名称 | | | | 时间 | 2018 年 10 月 9 日 | | | 地点 | 公司会议室 | | | 上市公司 | 张晓南 宋伟 | | | 接待人员 | | | | 姓名 | | | | 投资者关 | 1 、公司未来发展方向 | | | 系活动主 要内容 | | 未来公司也将坚持关注有技术的市场，投资有市场的技 | | | | 术，以反渗透膜技术资源为基点 ...

编号：202101 证券代码：000920 证券简称：南方汇通 南方汇通股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------|------------------------------|--------------------------------------------------------| | | | | | 投资者关 | ☑ 特定对象调研 | □ 分析师会议 | | 系活动类 | □ 媒体采访 | □ 业绩说明会 | | 别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | □ 其他 | | | 参 与 单 | 国泰君安证券股份有限公司 | | | 位名称 | | | | 时间 | 2021 年 1 月 22 日 | | | 地点 | 公司会议室 | | | 上市公司 | 蔡志奇等 | | | 接待人员 | | | | 姓名 | | | | 投资者关 | 1 | 、公司的战略定位和未来的并购方向 | | 系活动主 要内容 | | 近年来，公司在产业研究和公司战略方向上持续探索，膜 | | | | 分离技术在水 ...

证券代码：000920 证券简称：沃顿科技 编号：202104 | --- | --- | --- | --- | |-------------------|--------------------------------|----------------------------------------------------------|-------| | | | | | | | | | | | | | | | | 投资者关 系活动类 | ☑ 特定对象调研 □ 媒体采访 | □ 分析师会议 □ 业绩说明会 | | | 别 | □ 新闻发布会 | □ 路演活动 | | | | □ 现场参观 | | | | | □ 其他 | | | | 参与单 | 上海申银万国证券研究所有限公司 | | | | 位名称 | | | | | 时间 | 2021 年 12 月 14 日 | | | | 地点 | 公司会议室 | | | | 上市公司 | 证券事务代表 宋伟女士 | | | | 接待人员 | | | | | 姓名 | | | | | | 1. 关于此次吸收合并的目的 | | | | | | 本次吸收合并时代沃顿有利 ...

证券代码：000920 证券简称：沃顿科技 沃顿科技股份有限公司投资者关系活动记录表 编号：202104 | --- | --- | --- | |-------------------|-------------------------------|----------------------------------------------------------| | | | | | | | | | 投资者关 | ☑ 特定对象调研 | □ 分析师会议 | | 系活动类 | □ 媒体采访 | □ 业绩说明会 | | 别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | □ 其他 | | | 参与单 | 华安证券股份有限公司 | | | 位名称 | | | | 时间 | 2021 年 12 月 21 日 | | | 地点 | 公司会议室 | | | 上市公司 | 证券事务代表 宋伟女士 | | | 接待人员 姓名 | | | | | 1. 公司主要膜产品 | | | | | | | | | 公司膜产品包括复合反渗透膜、纳滤膜、超滤膜等，按使用场景 | | | 分为家用膜、工业膜两 ...

重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、 准确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带 的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员) 声明：保证季度报告中财务信息的真实、准确、完整。 3.第三季度报告是否经过审计 □是 √否 1 沃顿科技股份有限公司 2022 年第三季度报告 | 证券代码：000920 | 证券简称：沃顿科技 | 公告编号：2022-063 | | --- | --- | --- | | 债券代码：112698 | 债券简称：18 南方 01 | | 沃顿科技股份有限公司 2022 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 沃顿科技股份有限公司 2022 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 √否 | | 本报告期 | 本报告期比上年同期 | 年初至报告期末 | 年初至报告期末比上 | | --- | --- | --- | --- | --- | ...

Financial Performance - The company's operating revenue for the first half of 2022 was ¥624,566,396.15, a decrease of 8.87% compared to ¥685,342,788.31 in the same period last year[19]. - Net profit attributable to shareholders increased by 6.18% to ¥63,207,843.84 from ¥59,528,749.59 year-on-year[19]. - The net profit after deducting non-recurring gains and losses rose by 16.96% to ¥58,538,015.91 compared to ¥50,048,054.58 in the previous year[19]. - The net cash flow from operating activities decreased by 18.46% to ¥115,266,478.27 from ¥141,357,884.10 in the same period last year[19]. - Basic and diluted earnings per share increased by 6.38% to ¥0.150 from ¥0.141 year-on-year[19]. - Total assets at the end of the reporting period were ¥2,399,673,633.74, down 2.32% from ¥2,456,718,831.48 at the end of the previous year[19]. - Net assets attributable to shareholders increased by 1.58% to ¥1,296,621,069.71 from ¥1,276,392,407.21 at the end of the previous year[19]. - The company's total sales revenue for the first half of 2022 was 624,566,396.15 CNY, a decrease of 8.87% compared to the same period last year[53]. - The sales revenue from membrane products reached 372,178,419.80 CNY, accounting for 59.59% of total revenue, with a year-on-year growth of 0.99%[56]. - The company reported a significant reduction in financial expenses by 73.27% due to decreased exchange losses[54]. - The gross profit margin for the other chemical manufacturing sector was 38.89%, showing a decrease of 2.45% compared to the previous year[57]. Market and Industry Trends - The membrane separation technology industry is experiencing significant growth due to increasing global water resource shortages and environmental issues, positioning it as a mainstream solution for industrial water resource utilization and pollution control[27]. - Domestic membrane technology and manufacturing capabilities have significantly improved, with the market for domestic brands expanding and gaining recognition, indicating a shift from growth to maturity in the membrane industry[28]. - The demand for industrial membranes is closely linked to the national economic performance and fixed asset investment, with increased demand during economic growth and decreased demand during economic downturns[28]. - The implementation of new water efficiency standards in July 2022 is expected to drive demand for high-performance and water-saving household membranes, enhancing market competitiveness for high-tech enterprises[30]. Research and Development - The company continues to focus on research and development of new products and technologies to enhance market competitiveness[26]. - The company specializes in the research, manufacturing, and sales of reverse osmosis membranes, nanofiltration membranes, and ultrafiltration membranes, catering to various applications including household, commercial, and industrial uses[31]. - The company has developed over 100 specifications across more than 20 series of membrane products, focusing on selective separation of salt and materials for various industries[32]. - Research and development investment increased by 6.28% to 39,236,500.84 CNY compared to the previous year[55]. - The company focuses on the research and production of composite reverse osmosis membranes, nanofiltration membranes, and ultrafiltration membranes, providing suitable membrane components for downstream water purification and resource recycling industries[36]. Risk Management - The management discussed potential risks and countermeasures in the report, highlighting the importance of risk management[4]. - The company faced risks related to overseas trade due to ongoing global pandemic impacts and geopolitical uncertainties affecting export operations[75]. - The company will closely monitor changes in overseas market conditions and adjust sales policies accordingly to enhance risk prevention capabilities[76]. - The company will establish a risk management mechanism for the conversion of R&D results to address potential failures in commercialization[77]. - The company will develop alternative supplier channels and maintain a safety buffer inventory for raw materials to mitigate risks from global inflation and supply chain disruptions[78]. Sales and Distribution - The company has established a dynamic production model based on sales feedback, allowing for monthly, weekly, and daily production planning to meet customer demands and ensure timely order delivery[36]. - The company has a comprehensive sales network covering most countries and regions globally, utilizing a "direct sales + distribution" model to enhance customer engagement and service[37]. - Daziran employs a mixed sales model combining distributor sales, online sales, and group sales, supported by nearly a thousand retail stores and e-commerce platforms[40]. Corporate Governance - The company has not implemented any equity incentive plans, employee stock ownership plans, or other employee incentive measures during the reporting period[87]. - The seventh board of directors and supervisory board members were elected on February 25, 2022, with key members including Mr. Cai Zhiqi and Mr. Jin Yan[113]. - The total number of ordinary shareholders at the end of the reporting period was 28,742, with no preferred shareholders[119]. - Major shareholder, CRRC Industry Investment Co., Ltd., holds 42.64% of the shares, totaling 179,940,000 shares[119]. Financial Position - The current ratio decreased to 127.81% from 168.75%, a decline of 40.94% compared to the end of the previous year[137]. - Total liabilities decreased to ¥979.48 million from ¥1,060.00 million, a reduction of ¥80.52 million[144]. - The company's total equity increased to ¥1,420.19 million from ¥1,396.72 million, an increase of ¥23.47 million[144]. - The inventory increased to ¥205.56 million from ¥159.83 million, an increase of 28.69%[142]. - The company maintained a loan repayment rate of 100% and an interest payment rate of 100%[137]. Future Outlook - The company plans to increase product innovation and develop a diverse product portfolio to maintain competitive advantages amid intensifying industry competition[76]. - The company plans to continue its market expansion and product development strategies to improve future performance[171]. - Future outlook indicates a focus on technological advancements and market expansion, with an emphasis on enhancing user data analytics capabilities[167]. - The company plans to explore potential mergers and acquisitions to bolster its competitive position in the market, although no specific targets have been disclosed[167].

Financial Performance - The company's operating revenue for 2021 was CNY 1,380,819,408.88, representing a 10.10% increase compared to CNY 1,254,114,952.97 in 2020[19] - The net profit attributable to shareholders for 2021 was CNY 121,381,996.33, which is a 14.56% increase from CNY 105,952,076.51 in the previous year[19] - The net cash flow from operating activities increased by 30.99% to CNY 236,324,961.06 in 2021, up from CNY 180,419,146.39 in 2020[19] - Basic earnings per share for 2021 were CNY 0.29, reflecting a 16.00% increase from CNY 0.25 in 2020[19] - The total operating cash inflow for 2021 was 1,460,053,415.06, up 23.72% from 2020[81] - The total operating cash outflow for 2021 was 1,223,728,454.00, an increase of 22.41% from 2020[81] - The operating profit for 2021 was CNY 15,102,980, reflecting a growth of 10.42% year-on-year[58] - The sales revenue of the membrane product segment increased by 18.80% year-on-year, amounting to 756.22 million yuan[55] - The sales revenue of the reclaimed water reuse segment grew by 37.54% compared to the previous year, enhancing brand effect[56] Assets and Liabilities - The total assets at the end of 2021 were CNY 2,456,718,831.48, a decrease of 2.56% from CNY 2,521,275,674.71 at the end of 2020[20] - The net assets attributable to shareholders increased by 4.88% to CNY 1,276,392,407.21 at the end of 2021, compared to CNY 1,217,026,315.44 at the end of 2020[20] - The company's monetary funds at the end of 2021 amounted to 648,486,122.15, representing 26.40% of total assets[85] - The long-term equity investment increased to 86,315,570.20, accounting for 3.51% of total assets, up 2.90% from the beginning of the year[85] Dividends and Shareholder Returns - The company plans to distribute a cash dividend of CNY 1.01 per 10 shares, totaling CNY 42,200,000 based on 422,000,000 shares[5] - The total cash dividend amount for the year was 42,622,000 CNY, representing 100% of the total profit distribution[153] - The company's available distributable profit at the end of the year was 566,351,399.91 CNY[154] Research and Development - The company achieved a research and development expenditure of 85.79 million yuan, an increase of 15.91% compared to the previous year, and holds a total of 126 valid patents, including 58 invention patents[47] - The company plans to continue R&D on composite reverse osmosis membranes, aiming to achieve new product industrialization and enhance market competitiveness[79] - The company is investing in R&D, allocating approximately 5 million for new technology development in the next fiscal year[125] Market Position and Strategy - The company is positioned as a domestic leader and internationally advanced in the membrane separation technology industry, with a focus on high-performance reverse osmosis and nanofiltration membranes[31] - The company anticipates increased market demand for household water purification solutions, particularly in lower-tier cities and rural areas, driven by rising awareness of drinking water safety[32] - The company aims to capitalize on favorable policies promoting water resource protection and wastewater recycling, which will drive growth in the membrane separation technology market[32] - The company is focused on expanding its market presence through innovative product development and strategic partnerships in the water treatment sector[36] - The company is actively developing new products and technologies, with a focus on polymer materials, which are expected to enhance competitive advantage[121] Supply Chain and Production - The company has a robust supply chain, with upstream dependencies on chemical raw materials and equipment, which significantly impact production costs[36] - The company has established a comprehensive production process for membrane preparation, including the use of polysulfone and other additives[36] - The company is actively expanding its production capacity with the ongoing construction of the third phase of the Shawan Industrial Park, optimizing production processes to support growth[56] Risk Management - The company has identified potential risks in its operations and outlined measures to address these risks in its future outlook[5] - The company faces risks from global economic uncertainties, inflation, and increased competition in the industry[105] - The company is actively involved in risk assessment and management, ensuring financial stability[135] Corporate Governance - The company held 22 board meetings during the reporting period, discussing key financial reports and strategic decisions[135] - The board of directors has been stable, with no significant changes in personnel during the reporting period[131] - The company has a structured decision-making process for executive remuneration based on performance metrics[132] Social Responsibility - The company actively engages in social responsibility initiatives and supports local economic development[168] - The company plans to donate a total of 800,000 RMB to Linjiatian Village for cattle breeding and mushroom cultivation projects over two years[172] - The company has committed to fulfilling its social responsibilities and supporting rural revitalization efforts[174] Compliance and Internal Control - The internal control system was effectively implemented, ensuring compliance with laws and regulations, and safeguarding shareholder interests[156] - There were no significant internal control deficiencies identified during the reporting period[157] - The company reported zero significant defects in financial reporting for 2021[162] Future Outlook - Future guidance suggests a projected revenue increase of 20% for the upcoming fiscal year, reflecting confidence in market expansion strategies[120] - The company plans to enhance its membrane business and expand its product line while optimizing its supply chain and sales channels[104] - The company intends to enhance its brand image and market competitiveness through increased marketing efforts and improved product quality standards[107]

Revenue and Profitability - Revenue for Q1 2022 was ¥313,141,167.81, a decrease of 0.66% compared to ¥315,224,055.11 in the same period last year[4] - Net profit attributable to shareholders increased by 101.23% to ¥20,342,006.15 from ¥10,108,977.02 year-on-year[4] - Basic and diluted earnings per share rose by 100.83% to ¥0.0482 from ¥0.0240 in the same period last year[4] - The net profit for Q1 2022 was CNY 21,259,968.34, a significant increase from CNY 10,976,484.53 in the same period last year, representing a growth of approximately 94.5%[19] - The total operating profit of CNY 21,650,730.34, an increase from CNY 13,904,640.63 year-over-year, marking a growth of approximately 55.5%[19] - The total comprehensive income for the period was CNY 14,081,924.43, compared to a loss of CNY 331,214.02 in the same quarter last year[20] Cash Flow and Financial Position - Net cash flow from operating activities was negative at -¥2,405,369.25, a decline of 110.02% compared to ¥23,994,817.62 in the previous year[9] - Cash flow from financing activities increased significantly by 1004.86% to ¥8,360,951.39 from -¥924,000.00 in the previous year[9] - The cash flow from operating activities showed a net outflow of CNY 2,405,369.25, a decline from a net inflow of CNY 23,994,817.62 in the previous year[23] - The cash flow from investing activities resulted in a net outflow of CNY 26,683,875.31, compared to a net outflow of CNY 19,293,190.34 in the previous year[23] - The cash flow from financing activities generated a net inflow of CNY 8,360,951.39, compared to a net outflow of CNY 924,000.00 in the same quarter last year[23] Assets and Liabilities - Total assets decreased by 1.57% to ¥2,418,214,711.11 from ¥2,456,718,831.48 at the end of the previous year[5] - Total liabilities decreased to RMB 1,007,182,389.02 from RMB 1,060,000,313.82, a reduction of about 5%[16] - The company's cash and cash equivalents decreased to RMB 594,279,885.74 from RMB 648,486,122.15 at the beginning of the year, a decline of approximately 8.3%[14] - Total assets decreased to RMB 2,418,214,711.11 from RMB 2,456,718,831.48, a decline of approximately 1.6%[15] Shareholder Equity and Investments - Shareholders' equity attributable to shareholders increased by 1.05% to ¥1,289,788,249.45 from ¥1,276,392,407.21 at the end of the previous year[5] - The company reported a net loss from investments of RMB 214,282.17, compared to a gain of RMB 783,083.54 in the previous year[18] - The company’s retained earnings increased to RMB 762,760,142.89 from RMB 742,209,444.74, reflecting a growth of approximately 2.4%[16] Operational Performance - Total operating revenue for Q1 2022 was RMB 313,141,167.81, a decrease of 0.34% from RMB 315,224,055.11 in the same period last year[18] - Total operating costs for Q1 2022 were RMB 294,996,356.07, down 2.93% from RMB 303,922,165.45 in the previous year[18] - Research and development expenses increased to RMB 20,689,496.37, up from RMB 19,289,256.39, reflecting a focus on innovation[18] - Accounts receivable increased by 102.82% to ¥48,931,827.98 from ¥24,125,420.72 due to increased customer credit amid the pandemic[8] - Inventory increased to RMB 190,509,046.41 from RMB 159,828,705.67, representing an increase of 19.2%[15] - Accounts receivable rose to RMB 48,931,827.98, compared to RMB 24,125,420.72 at the start of the year, indicating a significant increase of 102.4%[14] - The company received government subsidies amounting to ¥4,301,735.60, an increase of 47.76% compared to ¥2,911,226.55 in the previous year[8] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 29,384[10] - The other comprehensive income after tax was a loss of CNY 7,178,043.91, compared to a loss of CNY 11,307,698.55 in the same period last year, showing an improvement[19]

沃顿科技股份有限公司 2021 年第三季度报告 | 证券代码：000920 | 证券简称：沃顿科技 | 公告编号：2021-078 | | --- | --- | --- | | 债券代码：112538 | 债券简称：17 | 汇通 01 | | 债券代码：112698 | 债券简称：18 | 南方 01 | 沃顿科技股份有限公司 2021 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导 性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准 确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法 律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声 明：保证季度报告中财务信息的真实、准确、完整。 3.第三季度报告是否经过审计 □ 是 √ 否 一、主要财务数据 (一)主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 1 沃顿科技股份有限公司 2021 年第三季度报告 | 总资产（元） | 2,383,174,030.55 | 2,521,275, ...